Christopher Schliehe

ORCID: 0000-0002-1923-8620

Also affiliated with Erasmus MC Cancer Institute

Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Challenges in developing personalized neoantigen cancer vaccines”.

Challenges in developing personalized neoantigen cancer vaccines

Nature reviews. Immunology(2023)10.1038/s41577-023-00937-y

N/A

0DataRank · unranked

232 citations

Ken J. Ishii, Christopher Schliehe, Peter D. Katsikis

Sec22b and Stx4 Depletion Has No Major Effect on Cross-Presentation of PLGA Microsphere–Encapsulated Antigen and a Synthetic Long Peptide In Vitro

The Journal of Immunology(2023)10.4049/jimmunol.2200473

N/A

0DataRank · unranked

5 citations

Jane S.A. Voerman, Mitchell A.A. Geleijnse, Laure S. van Hofwegen, Anneloes van Krimpen, Julia Koerner +4 more

CTG-Initiated Cryptic Peptide Translation Up- and Downstream of a Canonical ATG Start Codon Is Enhanced by TLR Stimulation and Induces Tumor Regression in Mice

Cancer Immunology Research(2025)10.1158/2326-6066.cir-24-0467

N/A

0DataRank · unranked

0 citations

Youkyung Lim, Anneloes van Krimpen, Mitchell A.A. Geleijnse, Manon Messchendorp, Jane S.A. Voerman +10 more